Department of Abdominal Surgery, St. Joseph Hospital (GHdC), Rue de la Duchère 6, 6060, Charleroi, Gilly, Belgium.
Surg Endosc. 2011 Feb;25(2):454-62. doi: 10.1007/s00464-010-1191-y. Epub 2010 Jul 7.
There are few reports that show that laparoscopic rectal surgery for rectal cancer had similar oncological results based on short-term benefits. The purpose of this study was to analyze our institutional short- and long-term results in laparoscopic rectal surgery and to compare these results with that reported in the literature.
The records of 121 patients who underwent sphincter-saving procedure for rectal cancer were reviewed. The variables analyzed included possible factors causing morbidity, anastomotic leak, and recurrence rate in the laparoscopic and open techniques. Multivariable analyses were used to determine relationship between variables. Survival curves were determined by using the Kaplan-Meier method.
Laparoscopic sphincter-saving total mesorectal excision or partial mesorectal excision was performed in 97 patients (group 1). Twenty-four patients had open procedure (group 2). The conversion rate from laparoscopic to open technique was 10.3% (n=10). The overall postoperative morbidity and anastomotic leak rates were 33.4% and 14.8%, respectively. There was no statistical difference in terms of postoperative morbidity (p=0.177) and anastomotic leak (p=0.216) between the two groups. Old age was an independent predictor for postoperative morbidity, and downstaging was an independent predictor for anastomotic leak with a sixfold increased risk. Complete downstaging to stage 0 showed a lower overall 5-year survival rate compared with non-downstaged stage I patients (79% vs. 100%). The overall local recurrence rate was 6%. There was one port site metastasis (0.8%). There were two (1.7%) postoperative deaths in group 1. The overall 5-year patient and disease-free survivals were 64% and 74%, respectively, and there was no difference between groups 1 and 2 (p=0.801).
Laparoscopic sphincter-saving rectal resection for rectal cancer shows good long-term results. However, it has no advantage in terms of short-term benefits compared with the open procedure. Further studies are needed to validate the effect of downstaging on anastomotic leaks.
仅有少数研究报道腹腔镜直肠手术治疗直肠癌具有相似的短期疗效和肿瘤学效果。本研究旨在分析本机构腹腔镜直肠手术的短期和长期结果,并与文献报道的结果进行比较。
回顾性分析 121 例接受保肛手术治疗直肠癌患者的病历资料。分析的变量包括腹腔镜和开腹手术中导致发病率、吻合口漏和复发率的可能因素。采用多变量分析确定变量之间的关系。采用 Kaplan-Meier 方法绘制生存曲线。
97 例患者(1 组)行腹腔镜保肛全直肠系膜切除术或部分直肠系膜切除术,24 例患者(2 组)行开腹手术。腹腔镜转为开腹手术的转化率为 10.3%(n=10)。总的术后发病率和吻合口漏发生率分别为 33.4%和 14.8%。两组在术后发病率(p=0.177)和吻合口漏(p=0.216)方面无统计学差异。高龄是术后发病率的独立预测因素,降期是吻合口漏的独立预测因素,其风险增加 6 倍。完全降期至 0 期的患者总 5 年生存率明显低于未降期的 I 期患者(79% vs. 100%)。局部复发率为 6%。有 1 例(0.8%)发生切口部位转移。1 组有 2 例(1.7%)术后死亡。1 组和 2 组的总 5 年患者生存率和无病生存率分别为 64%和 74%,两组间差异无统计学意义(p=0.801)。
腹腔镜直肠保肛切除术治疗直肠癌具有良好的长期效果。但与开腹手术相比,其短期疗效并无优势。需要进一步研究降期对吻合口漏的影响。